MC2 THERAPEUTICS LTD has a total of 22 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals are GILA THERAPEUTICS INC, AEQUUS PHARMACEUTICALS INC and LABORATORIO RAAM DE SAHUAYO S A DE C V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Brazil | 3 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Crutchley Nigel | 17 |
#2 | Georgiou Michelle | 14 |
#3 | Praestegaard Morten | 9 |
#4 | Lenon Stephen | 9 |
#5 | Nigel Crutchley | 5 |
#6 | Michelle Georgiou | 4 |
#7 | Stephen Lenon | 1 |
#8 | Morten Praestegaard | 1 |
Publication | Filing date | Title |
---|---|---|
BR112020025884A2 | composition for topical application, packaging, and method for making a composition | |
EP3542788A1 | Topical composition comprising calcipotriol and betamethasone dipropionate |